BD and Biosero collaborate to integrate robotic automation with flow cytometry technology, aiming to accelerate drug discovery.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...
BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...
BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to ...
Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it ...
Becton, Dickinson and Company and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a ...
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic ...
Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AIâ„¢ software at SLAS2025 in San Diego, January 27-29.
Danaher Corporation DHR is scheduled to release fourth-quarter 2024 results on Jan. 29, before market open. Stay up-to-date ...
This design enables a narrow linewidth (typically 20 MHz at 450 nm) and wavelength precision. Additionally, the lasers ...
The partners plan to expand testing for early detection of childhood leukemias and lymphomas, bolster local testing capacity, and conduct a research study.